Artemis Medicare Services (ARTEMISMED) Fundamentals 2026 — P/E 39.0x, Revenue Analysis | SniperIQ
Artemis Medicare Services (ARTEMISMED) is a India-listed Healthcare company in Medical - Care Facilities with a market capitalization of ₹4,321 Crore, trading at ₹273.45 on the NSE. This SniperIQ fundamentals page covers Artemis Medicare Services's valuation (P/E 39.0x, P/B 4.6x), profitability (net margin 9.6%), revenue (₹1,081 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Artemis Medicare Services's market cap?
Artemis Medicare Services (ARTEMISMED) has a market capitalization of approximately ₹4,321 Crore, trading at ₹273.45 on the NSE. Market cap moves with the live share price.
What is Artemis Medicare Services's P/E ratio?
Artemis Medicare Services's trailing twelve-month P/E ratio is 39.0x, with a price-to-book (P/B) of 4.6x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Artemis Medicare Services?
Artemis Medicare Services runs a net profit margin of 9.6%, a gross margin of 19.9%, and an operating margin of 13.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Artemis Medicare Services generate?
Artemis Medicare Services reported revenue of ₹1,081 Crore for fiscal year 2026, with net income of ₹104 Crore and earnings per share (EPS) of 6.56. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Artemis Medicare Services pay a dividend?
Artemis Medicare Services offers a trailing dividend yield of about 0.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Artemis Medicare Services financially healthy?
Artemis Medicare Services carries a debt-to-equity ratio of 0.28x and a current ratio of 1.74x, with a market beta of 0.27. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Artemis Medicare Services a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Artemis Medicare Services (ARTEMISMED) the key facts are: market cap ₹4,321 Crore, P/E 39.0x, revenue ₹1,081 Crore, 52-week range 203.35-297.5. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Artemis Medicare Services's full fundamentals live
Get Artemis Medicare Services's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.